Burning Rock Biotech (BNR) Change in Cash (2021 - 2025)

Burning Rock Biotech's Change in Cash history runs 5 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• In Q4 2025, Change in Cash fell 38.42% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at -$2.4 million (up 90.31% YoY), while the FY2025 annual figure was -$5.9 million, up 53.93% from the prior year.
• Change in Cash was $2.0 million for Q4 2025 at Burning Rock Biotech, up from $1.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $29.0 million in Q1 2021 to a low of -$76.0 million in Q4 2021.
• Historically, Change in Cash has averaged -$17.4 million across 5 years, with a median of -$13.2 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 189.48% in 2022, then soared 208.04% in 2024.
• A 5-year view of Change in Cash shows it stood at -$76.0 million in 2021, then advanced by 2.01% to -$74.5 million in 2022, then surged by 95.93% to -$3.0 million in 2023, then jumped by 208.04% to $3.3 million in 2024, then plunged by 38.42% to $2.0 million in 2025.
• The last three Change in Cash figures came in at $2.0 million (Q4 2025), $1.7 million (Q3 2025), and -$9.4 million (Q2 2025), per Business Quant data.